Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of .

is an emerging yeast pathogen that has recently caused major outbreaks in healthcare facilities worldwide. Clinical isolates are usually resistant to fluconazole and readily develop resistance to echinocandins and amphotericin B (AMB) during treatment. We describe here an interesting case of infection in an immunocompromised patient who had previously received AMB and caspofungin treatment.

First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.

Objective: C. nivariensis is a rare Candida species which is phenotypically closely related to Candida glabrata and Candida bracarensis. The 3 species form the C.

Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome.

Purpose: Candida auris is a recently recognized yeast pathogen, which has attracted worldwide attention due to its multidrug-resistant nature and associated high mortality rates. Its persistence in hospital environment and propensity of nosocomial transmission underscores the need of continuous monitoring to prevent outbreaks. Since the first case of C.